BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Gastric cancer AND TOP2A, TOP2, TP2A AND Treatment
13 results:

  • 1. Systems Pharmacology-Based Strategy to Investigate the Mechanism of Ruangan Lidan Decoction for treatment of Hepatocellular Carcinoma.
    Chen C; Liang T; Wu Q; Zhou Z; Zhang M; Feng D; Tao J; Si T; Cai M
    Comput Math Methods Med; 2022; 2022():2940654. PubMed ID: 36578460
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. MC180295 Inhibited Epstein-Barr Virus-Associated gastric Carcinoma Cell Growth by Suppressing DNA Repair and the Cell Cycle.
    Fujii T; Nishikawa J; Fukuda S; Kubota N; Nojima J; Fujisawa K; Ogawa R; Goto A; Hamabe K; Hashimoto S; Wai AP; Iizasa H; Yoshiyama H; Sakai K; Suehiro Y; Yamasaki T; Takami T
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142506
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Develop a circular RNA-related regulatory network associated with prognosis of gastric cancer.
    Wei S; Teng S; Yao J; Gao W; Zang J; Wang G; Hu Z
    Cancer Med; 2020 Nov; 9(22):8589-8599. PubMed ID: 32902196
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. iTRAQ‑based proteomics analysis of the therapeutic effects of combined anticancer bioactive peptides and oxaliplatin on gastric cancer cells.
    Xu Y; Li X; Su X
    Oncol Rep; 2020 Jan; 43(1):201-217. PubMed ID: 31746436
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Biomarker-Driven Therapy in Metastatic gastric and Esophageal cancer: Real-Life Clinical Experience.
    Purim O; Beny A; Inbar M; Shulman K; Brenner B; Dudnik E; Bokstein F; Temper M; Limon D; Matceyevsky D; Sarid D; Segal A; Semenisty V; Brenner R; Peretz T; Idelevich E; Pelles-Avraham S; Meirovitz A; Figer A; Russell K; Voss A; Dvir A; Soussan-Gutman L; Hubert A
    Target Oncol; 2018 Apr; 13(2):217-226. PubMed ID: 29353436
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Clinical significance of UGT1A1 polymorphism and expression of ERCC1, BRCA1, TYMS, RRM1, TUBB3, STMN1 and top2a in gastric cancer.
    Cao Y; Zhang G; Wang P; Zhou J; Gan W; Song Y; Huang L; Zhang Y; Luo G; Gong J; Zhang L
    BMC Gastroenterol; 2017 Jan; 17(1):2. PubMed ID: 28056823
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. BTG1 expression correlates with pathogenesis, aggressive behaviors and prognosis of gastric cancer: a potential target for gene therapy.
    Zheng HC; Li J; Shen DF; Yang XF; Zhao S; Wu YZ; Takano Y; Sun HZ; Su RJ; Luo JS; Gou WF
    Oncotarget; 2015 Aug; 6(23):19685-705. PubMed ID: 26050197
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Tumor profiling of gastric and esophageal carcinoma reveal different treatment options.
    Miura JT; Xiu J; Thomas J; George B; Carron BR; Tsai S; Johnston FM; Turaga KK; Gamblin TC
    Cancer Biol Ther; 2015; 16(5):764-9. PubMed ID: 25778705
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Detection of kinase amplifications in gastric adenocarcinomas.
    Özdemiri M; Öznur M; Çiftçi E; Durak Aras B; Aslan H; Saygili H; Öner KS; Erkasap SM; Özakyol A; Paşaoğlu Ö; Çilingir O; Artan S
    Turk J Med Sci; 2014; 44(3):461-70. PubMed ID: 25558650
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Tissue-specific selection of optimal reference genes for expression analysis of anti-cancer drug-related genes in tumor samples using quantitative real-time RT-PCR.
    Wang H; Yang B; Geng T; Li B; Dai P; Chen C
    Exp Mol Pathol; 2015 Jun; 98(3):375-81. PubMed ID: 25445497
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Evidence for predictive role of BRCA1 and bTUBIII in gastric cancer.
    Moiseyenko VM; Volkov NM; Suspistin EN; Yanus GA; Iyevleva AG; Kuligina ESh; Togo AV; Kornilov AV; Ivantsov AO; Imyanitov EN
    Med Oncol; 2013 Jun; 30(2):545. PubMed ID: 23532817
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. 17q12-21 - the pursuit of targeted therapy in breast cancer.
    Glynn RW; Miller N; Kerin MJ
    Cancer Treat Rev; 2010 May; 36(3):224-9. PubMed ID: 20100636
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Concise prediction models of anticancer efficacy of 8 drugs using expression data from 12 selected genes.
    Tanaka T; Tanimoto K; Otani K; Satoh K; Ohtaki M; Yoshida K; Toge T; Yahata H; Tanaka S; Chayama K; Okazaki Y; Hayashizaki Y; Hiyama K; Nishiyama M
    Int J Cancer; 2004 Sep; 111(4):617-26. PubMed ID: 15239142
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.